Target intelligence / Profile preview

Protein odd-skipped-related 1 (OSR1)

Target
OSR1
Molecular classification
Transcription factor, Protein kinase (serine/threonine kinase, specifically GCK-VI subfamily of Ste20 group kinases), Zinc finger protein
01

Overview

OSR1 (Protein odd-skipped-related 1) is a zinc-finger transcription factor and serine/threonine kinase encoded by the OSR1 gene in humans. It plays critical roles in embryonic development of the kidney, heart, palate, and limbs, acting both through regulation of gene expression (as a transcription factor) and by phosphorylation of target proteins in key signaling pathways (as a protein kinase of the Ste20 family)[1][2][3][4][5]. OSR1 is an upstream regulator of cell differentiation and interacts with other transcription factors (e.g., Pax2, Wt1, Lhx1) essential for urogenital formation[1]. In cell signaling, OSR1 controls activity of sodium-potassium-chloride transporters by phosphorylation, a mechanism linked to rare inherited forms of hypertension and other developmental anomalies[2][5]. Loss or dysregulation of OSR1 can lead to kidney agenesis, heart malformations, and abnormal cell fate specification, making it important in disease modeling and a potential therapeutic target for organogenesis-related defects and hypertension[1][4][5].

Other names
Odd-skipped related transcription factor 1ODDOdd-skipped related 1OSR1 kinaseOxidative stress-responsive kinase 1
02

Mechanism of action

Experimental inhibitors can disrupt kinase activity, especially affecting the WNK-SPAK/OSR1 signaling axis and downstream ion cotransporters[5].

03

Biological functions

Embryonic development (kidney, heart, palate, limbs)Urogenital differentiation (regulation of renal and gonadal structures)Cell signaling (regulation of NKCCs, Na/K/Cl cotransporters)Fibroblast identity and extracellular matrix regulationRegulation of chemokine signaling and immune response genes
04

Disease associations

Hypertension (Gordon syndrome, via regulation of ion transporters by WNK-SPAK/OSR1 pathway)Congenital kidney and heart malformationsFibrosis and abnormal tissue differentiation (tendon, cartilage)Other developmental disorders
05

Safety considerations

Potential for off-target embryonic and organ development toxicity if OSR1-related pathways are inhibited[1][4]Unknown long-term safety profile due to absence of approved drugs directly targeting OSR1

Beyond the preview

Go deeper on Protein odd-skipped-related 1 (OSR1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein odd-skipped-related 1 (OSR1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call